- Over the past three years, EMA and the EUnetHTA 21 (European Network for Health Technology Assessment) consortium have delivered a number of milestones…
- EMA’s human medicines committee (CHMP) has recommended not renewing the conditional marketing authorisation for Blenrep (belantamab mafodotin), a…
- Nine new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended nine medicines for approval at its September 2023 meeting….
- EMA’s human medicines committee (CHMP) has recommended not renewing the marketing authorisation for Translarna (ataluren), a medicine for treating…
- EMA’s human medicines committee (CHMP) has recommended authorising an adapted Spikevax vaccine targeting the Omicron XBB.1.5 subvariant.The vaccine —…
- CVMP opinions on veterinary medicinal productsUnder Regulation (EC) No 726/2004, the Committee adopted by consensus a positive opinion for a marketing…
- PRAC recommends new measures to avoid topiramate exposure in pregnancyEMA’s safety committee (PRAC) recommends new measures to avoid exposure of children…
- Further restrictions on use; pregnancy prevention programme to be put in placeEMA’s safety committee (PRAC) recommends new measures to avoid exposure of…
- EMA’s human medicines committee (CHMP) has recommended authorising an adapted Comirnaty vaccine targeting the Omicron XBB.1.5 subvariant.The vaccine –…